Patents by Inventor Sam H. Whiting

Sam H. Whiting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190275038
    Abstract: The invention relates to methods of treating cancer or myeloproliferative diseaseswith a combination of a glutaminase inhibitor and an anticancer agent selected from cabozantinib, crizotinib, and axitinib. The invention further relates to methods of treating cancer or myeloproliferative diseases that are resistant to one or more anticancer agents.
    Type: Application
    Filed: March 14, 2019
    Publication date: September 12, 2019
    Inventors: Francesco Parlati, Keith Orford, Sam H. Whiting
  • Patent number: 10278968
    Abstract: The invention relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and an anticancer agent selected from cabozantinib, crizotinib, and axitinib. The invention further relates to methods of treating cancer or myeloproliferative diseases that are resistant to one or more anticancer agents.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: May 7, 2019
    Assignee: Calithera Biosciences, Inc.
    Inventors: Francesco Parlati, Keith Orford, Sam H. Whiting
  • Publication number: 20180055843
    Abstract: The invention relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and an anticancer agent selected from cabozantinib, crizotinib, and axitinib. The invention further relates to methods of treating cancer or myeloproliferative diseases that are resistant to one or more anticancer agents.
    Type: Application
    Filed: August 25, 2017
    Publication date: March 1, 2018
    Inventors: Francesco Parlati, Keith Orford, Sam H. Whiting